Atrial FibrillationESC 2017 Apixaban vs conventional therapy in patients with Afib undergoing cardioversion Medhat Share 0 Min Read http://cardiologynownews.org/wp-content/uploads/2017/12/2033-2005.mp4 TAGGED:anticoagulantApixabanAtrial FibrillationcardiversionConferenceEMANATEESC 2017 Share This Article Copy Link Print Leave a Comment Leave a Reply Cancel replyYou must be logged in to post a comment.
